Extracellular Vesicles 2017

Posted by: Exosome RNA Administrator in Conferences June 6, 2017 0 3,937 Views

Date: Tuesday, 26 September 2017 – Thursday, 28 September 2017

Location: Cripps Court, Magdalene College, Cambridge, UK

Despite the rapid development and huge potential seen in extracellular vesicle research, there is still much debate, over even some of the most basic biological questions. How exactly are they produced in vivo? How do you define them? How should they be isolated? What cargoes do they carry? How should we distinguish between them?

The discussion and investigation of these important challenges are likely to hold at least some of the keys to their successful diagnostic and therapeutic application. With a great deal of interest and investment being directed towards the benefits that extracellular vesicles promise, now more than ever there is cause and occasion for dialog and collaboration.

We welcome you to seize this opportunity to immerse yourself in cutting edge extracellular vesicle research. Interact and network with academic and industry leaders who are dedicated to unlocking the potential of these vital mediators of intercellular communication for diagnostic and therapeutic innovation.

Keep me updated

Call for Posters

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!

Poster Submission Deadline: 15 September 2017

Agenda Topics

Ageing, Cancer, Tissue Repair and Thrombosis
Biogenesis and Intercellular Communication
Biomarkers and Diagnostic Development
Extracellular Nucleic Acids, including miRNAs
Heterogeneity, Isolation, Purification and Characterisation
Quality Control and Standardisation
Therapeutic Potential of Extracellular Vesicles

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Confirmed Speakers to date

Stefania Bruno, Assistant Professor, University of Torino
Amy Buck, Assistant Professor, University of Edinburgh Medical School
David Carter, Senior Lecturer, Oxford Brookes University
Randolph Corteling, Head of Cell Biology, ReNeuron
Camille Ettelaie, Lecturer, University of Hull
Susanne Gabrielsson, Associate Professor, Karolinska University Hospital Solna
Deborah Goberdhan, Professor, University Of Oxford
Andrew Hoffman, Professor, Director — Regenerative Medicine Laboratory, Tufts University
Shannon Holliday, Associate Professor, University of Florida
Jennifer Jones, Assistant Clinical Investigator, National Institutes of Health
Marcin Jurga, R&D Manager, The Cell Factory (Esperite)
Lucia Languino, Professor, Thomas Jefferson University
David Larocca, Vice President Research and Development, ReCyte Therapeutics
Nigel Mackman, John Parker Professor, University of North Carolina Chapel Hill
Imre Mäger, Postdoctoral research scientist and Exosome team leader, University of Oxford
A. C. Matin, Professor, Stanford University
John Pezacki, Professor, University of Ottawa
Neta Regev-Rudzki, Professor, Department of Biomolecular Sciences, Weizmann Institute of Science
Kirsi Rilla, Group Leader, University of Eastern Finland
Paul Robbins, Professor, The Scripps Research Institute
Remy Sadoul, Professor, Grenoble Institut des Neurosciences
Lesley Smyth, Senior Lecturer, University of East London
Ciro Tetta, Chief Project Manager, Unicyte AG
Guillaume Van Niel, Research Scientist, Institute Curie
Mark Wilson, Senior Scientist: Immunology Discovery, Genentech